Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate

Critical illnesses associated with coronavirus disease 2019 (COVID-19) are attributable to a hypercoagulable status. There is limited knowledge regarding the dynamic changes in coagulation factors among COVID-19 patients on nafamostat mesylate, a potential therapeutic anticoagulant for COVID-19. Fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Osawa, Itsuki, Okamoto, Koh, Ikeda, Mahoko, Otani, Amato, Wakimoto, Yuji, Yamashita, Marie, Shinohara, Takayuki, Kanno, Yoshiaki, Jubishi, Daisuke, Kurano, Makoto, Harada, Sohei, Okugawa, Shu, Yatomi, Yutaka, Moriya, Kyoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486975/
https://www.ncbi.nlm.nih.gov/pubmed/32920751
http://dx.doi.org/10.1007/s11239-020-02275-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486975/
https://www.ncbi.nlm.nih.gov/pubmed/32920751
http://dx.doi.org/10.1007/s11239-020-02275-5

Ejemplares similares